期刊文献+

FGF21在小鼠非酒精性脂肪肝病程中的变化及与SREBP的相关性 被引量:5

FGF21 Expression During the Course of Mice NAFLD and Its Correlation with SREBP
下载PDF
导出
摘要 【目的】探讨成纤维细胞生长因子(FGF21)在小鼠非酒精性脂肪肝病程中肝组织和血清中的变化及其与胆固醇调节元件结合蛋白(SREBP)的相关性,探讨其中的可能机制。【方法】分别给予C57BL/6小鼠素食和高脂饮食喂养1、9、18周,Western blot和实时荧光定量RT-PCR检测肝脏组织FGF21和SREBP的表达,并分析二者的相关性;ELISA法检测小鼠血清的FGF21水平,分析血清FGF21水平与肝组织FGF21的蛋白和m RNA水平的相关性。【结果】高脂饮食喂养至9周时,小鼠肝脏的大体外观呈典型脂肪肝表现,至18周时HE染色可见肝细胞内大量的脂质颗粒聚集。与素食喂养小鼠相比,小鼠肝组织FGF21 m RNA水平在高脂饮食喂养至9周和18周时明显升高(均P<0.05),与高脂饮食的时间呈正相关(r=0.952,P=0.000)并同时与SREBP m RNA水平正相关(r=0.725,P=0.000)。而与素食喂养小鼠相比,小鼠肝组织FGF21蛋白在高脂饮食喂养至9周和18周时明显降低(P<0.05),SREBP蛋白表达则呈相反的趋势。血清的FGF21水平,与素食喂养相比,在高脂饮食喂养至9周和18周时明显升高(均P<0.05),与高脂饮食的时间呈正相关(r=0.944,P=0.000),与肝组织的FGF21蛋白水平负相关(r=-0.704,P=0.000),与FGF21 m RNA水平正相关(r=0.910,P=0.000)。【结论】在小鼠脂肪肝的逐渐进展中,肝组织FGF21 m RNA水平升高,蛋白水平降低,血清水平升高,并伴随SREBP的表达升高,提示肝脏中FGF21转录合成增加同时分泌亦明显增加,并与肝脏脂质合成及沉积密切相关。 【Objective】 To investigate the fibroblast growth factor 21(FGF21) expression in liver tissue and serum from different stage of mice nonalcoholic fatty liver disease(NALFD) and its correlation with SREBP. 【Method】C57BL / 6 mice were fed with chow diet and high fat diet(HFD) for 1, 9, and 18 weeks. Expressions of FGF21 and SREBP in liver tissue of mice were detected by western blot and real time RT-PCR. Serum FGF21 was examined using ELISA. The correlation of FGF21 and SREBP was statistically analyzed. 【Result】 The liver of mice exhibited typical appearance of fatty liver after 9 weeks of HFD. A large amount of fat granules accumulation was found in hepatocytes from mice fed with HFD for 18 weeks. Compared with mice fed with chow diet, FGF21 m RNA level in liver tissue from mice fed with HFD began dramatically higher on 9th and 18 th week of HFD(both P〈0.05), with positive correlation to the duration of HFD(r = 0.952, P = 0.000) and the SREBP m RNA level(r = 0.725, P = 0.000). On the other hand,FGF21 protein expression in liver tissue from mice fed with HFD statistically decreased on 9th and 18 th week of HFD compared with mice of chow diet(both P〈0.05). Opposite changes were found in the expression of SREBP protein. Furthermore, compared with mice of chow diet, serum FGF21 of HFD mice wasobviously higher on 9th and 18 th week of HFD(both P〈0.05), with positive correlation to the duration of HFD(r = 0.944,P = 0.000) and the FGF21 m RNA level of liver tissue(r = 0.910, P = 0.000), and negative correlation to the protein expression of FGF21 in liver tissue(r =-0.704,P = 0.000). 【Conclusion】 In the course of mice NAFLD, FGF21 m RNA level of liver tissue increased, protein expression decreased, and serum level became higher, accompanying by the elevation of SREBP in liver. That suggests a high secretion of FGF21 would appear with a high level of transcription and synthesis of FGF21 in liver under HFD, which is closely correlated with hepatic steatosis.
出处 《中山大学学报(医学科学版)》 CAS CSCD 北大核心 2016年第1期29-33,39,共6页 Journal of Sun Yat-Sen University:Medical Sciences
基金 国家自然科学基金(81470848)
关键词 非酒精性脂肪性肝病 FGF21 SREBP nonalcoholic fatty liver disease(NALFD) FGF21 SREBP
  • 相关文献

参考文献14

  • 1FABBRINI E, MAGKOS F. Hepatic steatosis as a marker of metabolic dysfunction[J]. Nutrients, 2015, 7 (6) : 4995-5019.
  • 2LEE MS, CHOI SE, HA ES, et al. Fibroblast growth factor-21 protects human skeletal muscle myotubes from palmitate-induced insulin resistance by inhibiting stress kinase and NF-KB [J]. Metabolism, 2012, 61 (8): 1142-1151.
  • 3XU J, LLOYD D J, HALE C, et al. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet- induced obese mice[J]. Diabetes, 2009, 58(1):250- 259.
  • 4SEMBA RD, SUN K, EGAN JM, et al. Relationship of serum fibroblast growth factor 21 with abnormal glucose metabolism and insulin resistance: the baltimore longitudinal study of aging[J]. J Clin Endocrinol Metab, 2012, 97(4) : 1375-1382.
  • 5LI H, FANG Q, GAO F, et al. Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride [J ]. J Hepatol, 2010, 53(5):934-940.
  • 6DAY CP, JAMES OF. Hepatic steatosis: innocent bystander or guilty party.9 [J ]. Hepatology, 1998, 27 (6) : 1463-1466.
  • 7HOTYA Y, NAKAMURA H, KONISHI M, et al. Fibroblast growth factor 21 regulates lipolysis in white adipose tissue lJut is not required for ketogenesis and trigtyceride clearance in liver[J]. Endocrinology, 2009, 150(10) : 4625-4633.
  • 8ZHANG Y, LEI T, HUANG JF, et al. The link between fibroblast growth factor 21 and sterol regulatory element binding protein lc during lipogenesis in hepatoeytes [ J ]. Mol Cell Endocrinol, 2011, 342(1-2): 41-47.
  • 9EMANUELLI B, VIENBERG SG, SMYTH G, et al. Interplay between FGF21 and insulin action in the liver regulates metabolism[J]. Clin Invest, 2014, 124(2): 515-527.
  • 10REINEHR T, WOELFLE J, WUNSCH R, et al. Fibroblast growth factor 21 (FGF-21) and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: a longitudinal analysis [J]. J Clin.Endoefinol Metab, 2012, 97(6): 2143-2150.

同被引文献57

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部